Future Science Group
Browse

sorry, we can't preview this file

Supplementary_Material_Regimen_Distribution_Supplement(1).docx (51.74 kB)

Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin’s lymphoma Supplementary Material Regimen Distribution Supplement

Download (51.74 kB)
dataset
posted on 2022-11-23, 14:33 authored by Alnecia R Nisbett, Xiaoqin Yang, Patrick Squires, Santosh Gautam, Kaushal Desai, Monika Raut, Akash Nahar

Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin’s lymphoma Supplementary Material Regimen Distribution Supplement

Funding

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA sponsored this study and provided financial support for the conduct of the research and for preparation of the article. AR Nisbett and S Gautam are employees of ConcertAI and report research funding from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA to their institution. X Yang, P Squires, K Desai, M Raut, and A Nahar are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and hold stock or stock options in Merck & Co., Inc., Kenilworth, NJ, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

History

Usage metrics

    Future Oncology

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC